| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGILE THERAPEUTICS INC | Director | Common Stock | 2.24K | $1.9K | $0.85 | Jun 9, 2022 | Direct |
| Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 70.3K | Dec 28, 2023 | Direct | ||
| AGILE THERAPEUTICS INC | Director | Employee Stock Option (Right to Buy) | 807 | Jun 9, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| AGRX | AGILE THERAPEUTICS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 10, 2022 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 3, 2021 | Director |
| AGRX | AGILE THERAPEUTICS INC | Jun 8, 2021 | 2 | $0 | 4 | Jun 10, 2021 | Director |